Philip Morris forecasts 2026 profit growth, but competitive pressures rise
#Philip Morris #Profit Forecast #IQOS #ZYN #Smoke-free products #Investor Relations #Financial Growth #Tobacco Regulation
📌 Key Takeaways
- Philip Morris International expects an annual profit growth of 11% to 13% through 2026.
- The company aims for smoke-free products to represent the vast majority of its revenue by 2030.
- Growth is heavily dependent on the success of ZYN nicotine pouches and IQOS heated tobacco.
- Rising competition from both traditional tobacco rivals and independent vape brands remains a significant risk.
📖 Full Retelling
🐦 Character Reactions (Tweets)
Sasha SmokescreenPhilip Morris is betting on smoke-free profits by 2026. Guess they finally decided that 'just not dying' is a better marketing strategy than 'smoking kills!' #TransformationTuesday
Nicotine NomadNothing screams 'growth' like switching from traditional cigarettes to fancy new stick sticks. Welcome to the age of futuristic fumes! #CigaretteRevolution
Market NinjaPhilip Morris forecasts profits while fighting the competition like it's The Hunger Games. May the healthiest company win! #TobaccoTyranny
Regulatory RebelAs PMI aims for smoke-free revenue, I can't wait to see them market their products as 'EDUCATED choices' for free thinkers everywhere! #NicotineGeek
💬 Character Dialogue
🏷️ Themes
Finance, Corporate Strategy, Tobacco Industry
📚 Related People & Topics
Iqos
Heated tobacco products by Philip Morris International
IQOS (/ˈaɪkoʊs/ EYE-kohs) is a line of heated tobacco products designed to be used with tobacco and nicotine-containing consumables. They are manufactured by Philip Morris International (PMI). The brand was first introduced in November 2014 in Japan and Italy.
Zyn (disambiguation)
Topics referred to by the same term
Zyn is a brand of nicotine pouches produced by Swedish Match.
Philip Morris
Topics referred to by the same term
Phil(l)ip or Phil Morris may refer to:
Investor relations
Company communication with investors
Investor relations (IR) is a "strategic management responsibility that is capable of integrating finance, communication, marketing and securities law compliance to enable the most effective two-way communication between a company, the financial community, and other constituencies, which ultimately c...
📄 Original Source Content
Philip Morris International forecast higher-than-expected 2026 profit on Friday, even as leading nicotine pouch brand Zyn struggles to fend off competitors eating into its market share. The world’s largest tobacco company by market capitalisation, which sells Marlboro outside the U.S., said it expects to grow adjusted earnings per share by 11.1% to 13.1% this year, beating analyst estimates. However, shares in the company fell 2.9% in pre-market trading. PMI investors have been rattled by a growing threat from rivals including British American Tobacco, which has been taking a larger share of category growth, raising concerns about Zyn’s momentum. The company said U.S. volumes of the nicotine pouch grew 19% in the fourth quarter, supported by a wide range of commercial activities. Similar initiatives in the third quarter, including a large one-off promotion costing $100 million, hit PMI’s shares as investors worried PMI would have to compromise on Zyn profitability to protect market share. The company said it anticipated up to $1.6 billion in investments to support growth of its newer products like Zyn and heated tobacco device IQOS. These products are also facing competitive pressures, which the company is betting on to replace revenues lost from cigarettes as smoking rates fall in some markets. PMI CEO Jacek Olczak said the company had a "remarkable" year that had seen it achieve its 2024-2026 targets ahead of schedule, leaving it on track to outperform this year. PMI renewed the targets for the period spanning 2026-2028. Olczak stated that this demonstrates the company's ability to create sustainable value for shareholders. However, analyst Callum Elliot from Bernstein noted that PMI’s results were mixed, with slightly lower revenues than forecast in the fourth quarter and a lack of specific guidance on U.S. Zyn growth. He indicated this is likely to be seen as a negative, stoking fears of ongoing share loss. Philip Morris expects full-year adjusted earnings...